Consolidated Portfolio Review Corp’s iShares iBonds Dec 2024 Term Treasury ETF IBTE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-31,055
Closed -$745K 397
2024
Q3
$745K Buy
31,055
+1,314
+4% +$31.5K 0.17% 152
2024
Q2
$713K Buy
29,741
+2,626
+10% +$62.8K 0.17% 151
2024
Q1
$649K Buy
27,115
+1,538
+6% +$36.8K 0.17% 138
2023
Q4
$610K Buy
25,577
+1,404
+6% +$33.5K 0.14% 154
2023
Q3
$576K Buy
24,173
+355
+1% +$8.45K 0.14% 160
2023
Q2
$567K Buy
23,818
+319
+1% +$7.62K 0.13% 155
2023
Q1
$564K Buy
+23,499
New +$561K 0.15% 148

Other funds holding IBTE

Consolidated Portfolio Review Corp's IBTE Position: Q4 2024 in Review

Consolidated Portfolio Review Corp sold out of iShares iBonds Dec 2024 Term Treasury ETF (IBTE) in Q4 2024, closing a stake of 31,055 shares — an estimated $745K sold.

Consolidated Portfolio Review Corp first reported a position in IBTE in Q1 2023 and held it in 7 quarters. The position peaked at $745K in Q3 2024. 5 funds tracked by Wall St. Rank hold IBTE as of Q4 2024.

  • Consolidated Portfolio Review Corp reported no remaining iShares iBonds Dec 2024 Term Treasury ETF position as of Q4 2024 after selling out during the quarter.
  • Consolidated Portfolio Review Corp sold 31,055 iShares iBonds Dec 2024 Term Treasury ETF shares in Q4 2024, an estimated $745K.
  • Consolidated Portfolio Review Corp first reported a position in iShares iBonds Dec 2024 Term Treasury ETF in Q1 2023 and held it in 7 quarters.
  • Consolidated Portfolio Review Corp's iShares iBonds Dec 2024 Term Treasury ETF position peaked at $745K in Q3 2024.
  • 5 funds tracked by Wall St. Rank held iShares iBonds Dec 2024 Term Treasury ETF as of Q4 2024.

Based on Consolidated Portfolio Review Corp's 13F filing for Q4 2024, filed 27 Jan 2025.